AK112

Clinical trials for AK112 explained in plain language.

Never miss a new study

Get alerted when new AK112 trials appear

Sign up with your email to follow new studies for AK112, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New combo aims to shrink rectal tumors without surgery

Disease control Recruiting now

This phase 2 trial tests a new approach for patients with a specific type of mid-low rectal cancer (pMMR/MSS). Participants receive a short course of radiation followed by six cycles of the immunotherapy drug ivonescimab. The goal is to see if this combination can make the cancer…

Matched conditions: AK112

Phase: PHASE2 • Sponsor: Zhejiang Cancer Hospital • Aim: Disease control

Last updated Aug 09, 2026 00:00 UTC

AK112

Get alerted when new AK112 trials appear

New combo aims to shrink rectal tumors without surgery